Virbac group
 
Group
Discover the
chairman's message 

 

Products
Meeting the customer’s essential
needs, across all therapeutic segments
and for most species
 
 
Innovation
A continuous
technological innovation
sensitive to the clients’ needs
Responsibility
Reporting its long-term development
is a natural move for Virbac

 

 
 
Investors
The latest financial information
 
Press
Subsidiaries,
sailing sponsorship...
discover the latest news
Career
A company’s success
is not built without respect
for the men and women behind it

A company dedicated
to animal health

Founded in 1968 by a French veterinarian, Virbac is an independent pharmaceutical company exclusively dedicated to animal health. Ranked 8th worldwide and present in more than 100 countries, the company offers a comprehensive range of products and services intended for veterinarians, farmers and animal owners.

Corporate news

Apr 01 - St Michel joins Virbac for Jean-Pierre Dick's new project

After his multihull season, Jean-Pierre Dick and his sponsors have decided to return to monohull racing. Official Sponsor since 2005, the StMichel biscuit brand has become the Principal Sponsor of the project, together with Virbac, the specialists in animal health.

Mar 24 - Australia: developing the ruminants vaccines of the future

Viva VIVID! summer 2013, Virbac Australia opened a new R&D centre in Penrith surrounded by those involved in the local animal health industry. A key event for the development of the subsidiary’s biological activity in food producing animals. Explanations by Robert Dempster, the local RDL manager.  

Feb 10 - Death of Pierre Pagès, member of the Virbac executive board

It is with immense sadness that Éric Marée, chairman of the executive board of Virbac along with all other members of the executive board must inform you of the death of Pierre Pagès, member of the executive board and head of Worldwide Operations, Thursday 6th February.  

Join Virbac

Job offers, career opportunities, firm values, testimonials... Discover our career section.

Customer driven innovation

To meet the client's essential needs, in all the therapeutic segments and for all species. Such is the philosophy of Virbac innovation. For this purpose, the laboratory develops...

Financial public releases

Apr 23 - PEA-PME eligibility of Virbac

  VIRBAC, listed on Euronext Paris

Apr 15 - 2014 first quarter consolidated sales

  Organic growth of +4.3% in the first quarter

Mar 19 - 2013 annual results

Current operating profit increases by 6.9% in 2013  

Corporate responsibility

Company culture, economic and social responsibility, citizenship, environment... From its very beginning, forty years ago, Virbac has taken a long-term view.